These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19807560)

  • 1. Towards a healthier discount procedure.
    Klock RM; Brouwer WB; Annemans LJ; Bos JM; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2005 Feb; 5(1):59-63. PubMed ID: 19807560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discounting future health gains: an empirical enquiry into the influence of growing life expectancy.
    Bobinac A; Brouwer W; van Exel J
    Health Econ; 2011 Jan; 20(1):111-9. PubMed ID: 20029933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discounting costs and effects: a reconsideration.
    van Hout BA
    Health Econ; 1998 Nov; 7(7):581-94. PubMed ID: 9845252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low tension between individual and societal time aspects in health improved outcomes.
    Ortendahl M; Fries JF
    J Clin Epidemiol; 2006 Nov; 59(11):1222-7. PubMed ID: 17027434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discounting health effects in pharmacoeconomic evaluations: current controversies.
    Bos JM; Postma MJ; Annemans L
    Pharmacoeconomics; 2005; 23(7):639-49. PubMed ID: 16173156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discounting for health effects in cost-benefit and cost-effectiveness analysis.
    Gravelle H; Smith D
    Health Econ; 2001 Oct; 10(7):587-99. PubMed ID: 11747043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Private and social time preferences for health and money: an empirical estimation.
    Lazaro A; Barberan R; Rubio E
    Health Econ; 2001 Jun; 10(4):351-6. PubMed ID: 11400257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framing health messages based on anomalies in time preference.
    Ortendahl M; Fries JF
    Med Sci Monit; 2005 Aug; 11(8):RA253-6. PubMed ID: 16049392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.
    Polinder S; Meerding WJ; van Exel J; Brouwer W
    Pharmacoeconomics; 2005; 23(8):791-802. PubMed ID: 16097841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discounting and risk characteristics in clinical decision-making.
    Ortendahl M; Fries JF
    Med Sci Monit; 2006 Mar; 12(3):RA41-5. PubMed ID: 16501432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH; Lass JH; Brown GC; Brown MM
    Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discounting in decision making: the consistency argument revisited empirically.
    Brouwer WB; van Exel NJ
    Health Policy; 2004 Feb; 67(2):187-94. PubMed ID: 14720636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention, policy, and paradox: what is the value of future health?
    Ganiats TG
    Am J Prev Med; 1997; 13(1):12-7. PubMed ID: 9037337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of publicly sponsored interventions on musculoskeletal injury claims in nursing homes.
    Park RM; Bushnell PT; Bailer AJ; Collins JW; Stayner LT
    Am J Ind Med; 2009 Sep; 52(9):683-97. PubMed ID: 19670260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discount rates in risk versus money and money versus money tradeoffs.
    Alberini A; Chiabai A
    Risk Anal; 2007 Apr; 27(2):483-98. PubMed ID: 17511713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time discounting and the body mass index. Evidence from the Netherlands.
    Borghans L; Golsteyn BH
    Econ Hum Biol; 2006 Jan; 4(1):39-61. PubMed ID: 16364701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time preference, time discounting, and smoking decisions.
    Khwaja A; Silverman D; Sloan F
    J Health Econ; 2007 Sep; 26(5):927-49. PubMed ID: 17574694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.